Phase II Study of Intramyocardial Injection of Autologous Bone Marrow Stem Cells for Refractory Angina in Patients With Normal or Slightly Reduced Left Ventricular Function.

Trial Profile

Phase II Study of Intramyocardial Injection of Autologous Bone Marrow Stem Cells for Refractory Angina in Patients With Normal or Slightly Reduced Left Ventricular Function.

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Jul 2014

At a glance

  • Drugs Autologous stem cell therapy (Primary)
  • Indications Angina pectoris
  • Focus Therapeutic Use
  • Acronyms ReACT
  • Sponsors CellPraxis
  • Most Recent Events

    • 23 Oct 2013 New source identified and integrated: ClinicalTrials.gov record.
    • 21 Nov 2012 New trial record
    • 06 Nov 2012 Results were reported in a Cryopraxis media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top